|
Name |
Thielavin A
|
Molecular Formula | C29H30O10 | |
IUPAC Name* |
4-[4-(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy-2-hydroxy-3,5,6-trimethylbenzoyl]oxy-2-hydroxy-3,5,6-trimethylbenzoic acid
|
|
SMILES |
CC1=CC(=C(C(=C1C(=O)OC2=C(C(=C(C(=C2C)C)C(=O)OC3=C(C(=C(C(=C3C)C)C(=O)O)O)C)O)C)O)C)O
|
|
InChI |
InChI=1S/C29H30O10/c1-10-9-18(30)15(6)22(31)19(10)28(36)38-26-14(5)12(3)21(24(33)17(26)8)29(37)39-25-13(4)11(2)20(27(34)35)23(32)16(25)7/h9,30-33H,1-8H3,(H,34,35)
|
|
InChIKey |
MGGMNKJGDSNTKZ-UHFFFAOYSA-N
|
|
Synonyms |
Thielavin A; 71950-66-8; 4-[4-(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy-2-hydroxy-3,5,6-trimethylbenzoyl]oxy-2-hydroxy-3,5,6-trimethylbenzoic acid; Thielavin-A; Benzoic acid,4-[(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy]-2-hydroxy-3,5,6-trimethyl-,4-carboxy-3-hydroxy-2,5,6-trimethylphenyl ester; DTXSID10222236; ZINC3647706; HY-N10225; CS-0106914; Benzoic acid, 4-((2,4-dihydroxy-3,6-dimethylbenzoyl)oxy)-2-hydroxy-3,5,6-trimethyl-, 4-carboxy-3-hydroxy-2,5,6-trimethylphenyl ester
|
|
CAS | 71950-66-8 | |
PubChem CID | 194424 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 538.5 | ALogp: | 7.4 |
HBD: | 5 | HBA: | 10 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 171.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 39 | QED Weighted: | 0.208 |
Caco-2 Permeability: | -5.733 | MDCK Permeability: | 0.00001110 |
Pgp-inhibitor: | 0.35 | Pgp-substrate: | 0.838 |
Human Intestinal Absorption (HIA): | 0.815 | 20% Bioavailability (F20%): | 0.499 |
30% Bioavailability (F30%): | 0.079 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 101.25% |
Volume Distribution (VD): | 0.266 | Fu: | 1.01% |
CYP1A2-inhibitor: | 0.059 | CYP1A2-substrate: | 0.839 |
CYP2C19-inhibitor: | 0.039 | CYP2C19-substrate: | 0.057 |
CYP2C9-inhibitor: | 0.558 | CYP2C9-substrate: | 0.072 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.107 |
CYP3A4-inhibitor: | 0.036 | CYP3A4-substrate: | 0.068 |
Clearance (CL): | 2.949 | Half-life (T1/2): | 0.556 |
hERG Blockers: | 0 | Human Hepatotoxicity (H-HT): | 0.078 |
Drug-inuced Liver Injury (DILI): | 0.718 | AMES Toxicity: | 0.034 |
Rat Oral Acute Toxicity: | 0.146 | Maximum Recommended Daily Dose: | 0.827 |
Skin Sensitization: | 0.688 | Carcinogencity: | 0.041 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.934 |
Respiratory Toxicity: | 0.078 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002085 | 0.864 | D0WY9N | 0.286 | ||||
ENC002078 | 0.720 | D04WJO | 0.228 | ||||
ENC003651 | 0.678 | D0FX2Q | 0.225 | ||||
ENC003680 | 0.664 | D0I3XG | 0.223 | ||||
ENC005301 | 0.570 | D0L5FY | 0.214 | ||||
ENC003695 | 0.566 | D03RTK | 0.212 | ||||
ENC004140 | 0.522 | D0FR9L | 0.209 | ||||
ENC003758 | 0.443 | D04ITO | 0.209 | ||||
ENC004141 | 0.438 | D0Q0PR | 0.202 | ||||
ENC003724 | 0.342 | D0N1FS | 0.200 |